Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Endocyte Enters Into Agreement to be Acquired by Novartis AG for $2.1 Billion

pharmafocusasiaNovember 28, 2018

Tag: endocyte , Novartis AG , acquisition , PSMA-617

PharmaSources Customer Service